These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2219678)

  • 61. Antinociceptive effects of oxymorphone-butorphanol-acepromazine combination in cats.
    Briggs SL; Sneed K; Sawyer DC
    Vet Surg; 1998; 27(5):466-72. PubMed ID: 9749518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomised clinical trial comparing clinically relevant sedation outcome measures in dogs after intramuscular administration of medetomidine in combination with midazolam or butorphanol for routine diagnostic imaging procedures.
    Le Chevallier D; Slingsby L; Murrell JC
    Vet J; 2018 Sep; 239():30-34. PubMed ID: 30197106
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of three sedative protocols on glomerular filtration rate in clinically normal dogs.
    Newell SM; Ko JC; Ginn PE; Heaton-Jones TG; Hyatt DA; Cardwell AL; Mauragis DF; Harrison JM
    Am J Vet Res; 1997 May; 58(5):446-50. PubMed ID: 9140548
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of acepromazine, butorphanol, or N-butylscopolammonium bromide on visceral and somatic nociception and duodenal motility in conscious horses.
    Sanchez LC; Elfenbein JR; Robertson SA
    Am J Vet Res; 2008 May; 69(5):579-85. PubMed ID: 18447787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of medetomidine and medetomidine-butorphanol combination on Schirmer tear test 1 readings in dogs.
    Sanchez RF; Mellor D; Mould J
    Vet Ophthalmol; 2006; 9(1):33-7. PubMed ID: 16409243
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the Sedative Effects of Alfaxalone and Butorphanol-Midazolam Administered Intramuscularly in Budgerigars (
    Escalante GC; Balko JA; Chinnadurai SK
    J Avian Med Surg; 2018 Dec; 32(4):279-285. PubMed ID: 31112640
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of analgesia and cardiorespiratory effects of epidurally administered butorphanol in isoflurane-anesthetized dogs.
    Troncy E; Cuvelliez SG; Blais D
    Am J Vet Res; 1996 Oct; 57(10):1478-82. PubMed ID: 8896688
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
    Greenwald MK; Stitzer ML
    Drug Alcohol Depend; 1998 Dec; 53(1):17-30. PubMed ID: 10933337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs.
    Dodman NH; Shuster L; White SD; Court MH; Parker D; Dixon R
    J Am Vet Med Assoc; 1988 Oct; 193(7):815-9. PubMed ID: 3192459
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Standing sedation in African elephants (Loxodonta africana) using detomidine-butorphanol combinations.
    Neiffer DL; Miller MA; Weber M; Stetter M; Fontenot DK; Robbins PK; Pye GW
    J Zoo Wildl Med; 2005 Jun; 36(2):250-6. PubMed ID: 17323566
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiorespiratory effects of a combination of medetomidine, midazolam, and butorphanol in dogs.
    Pypendop B; Verstegen J
    Am J Vet Res; 1999 Sep; 60(9):1148-54. PubMed ID: 10490087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of anesthetic regimens on the perioperative catecholamine response associated with onychectomy in cats.
    Lin HC; Benson GJ; Thurmon JC; Tranquilli WJ; Olson WA; Bevill RF
    Am J Vet Res; 1993 Oct; 54(10):1721-4. PubMed ID: 8250399
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 75. Dose response to butorphanol administered subcutaneously to increase visceral nociceptive threshold in dogs.
    Sawyer DC; Rech RH; Durham RA; Adams T; Richter MA; Striler EL
    Am J Vet Res; 1991 Nov; 52(11):1826-30. PubMed ID: 1785725
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of transdermal fentanyl solution application and subsequent naloxone hydrochloride administration on minimum alveolar concentration of isoflurane in dogs.
    Grasso SC; Ko JC; Weil AB; Hess JA; Paranjape V; Payton M
    J Am Vet Med Assoc; 2018 Aug; 253(4):431-436. PubMed ID: 30058966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Changes in pupil size and intraocular pressure after topical application of 0.5% tropicamide to the eyes of dogs sedated with butorphanol.
    Jugant S; Grillot AE; Lyarzhri F; Régnier A; Douet JY
    Am J Vet Res; 2019 Jan; 80(1):95-101. PubMed ID: 30605033
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of potency and duration of action of nalmefene and naloxone.
    Glass PS; Jhaveri RM; Smith LR
    Anesth Analg; 1994 Mar; 78(3):536-41. PubMed ID: 8109774
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of a xylazine constant rate infusion with or without butorphanol for standing sedation of horses.
    Ringer SK; Portier KG; Fourel I; Bettschart-Wolfensberger R
    Vet Anaesth Analg; 2012 Jan; 39(1):1-11. PubMed ID: 22103355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
    Oliveto A; Sevarino K; McCance-Katz E; Feingold A
    Pharmacol Biochem Behav; 2002; 71(1-2):85-96. PubMed ID: 11812511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.